Page 13 - Fpgee Question And Answer 2024 Edition

www.pharmacyexam.com Krisman

a. Suffering from hypertension or ischemic c. Prevention of nausea and vomiting
heart disease. associated with emetogenic cancer therapy.
b. Taking MAO inhibitors. d. Diabetes
c. Taking Dihydroergotamine.
d. Suffering from L. pneumonia. 978. Dolasetron (Anzemet) therapy should be
monitored by regularly checking:
973. When Levodopa+ Carbidopa are to be given
to patients who are being treated with a. ECG
Levodopa, Levodopa must be discontinued b. CAT scan
at least: c. COMB’s Test
d. Antinuclear Antibody Test
a. 4 hours before therapy with Levodopa+
Carbidopa is initiated. 979. Leflunomide (Arava) is contraindicated to
b. 8 hours before therapy with Levodopa+ use in patients suffering from:
Carbidopa is initiated.
c. 12 hours before therapy with Levodopa+ a. Hypertension
Carbidopa is initiated. b. Pregnancy
d. 24 hours before therapy with Levodopa+ c. Arrhythmia
Carbidopa is initiated. d. Depression

974. Pergolide (Permax) is indicated for the 980. The most frequently reported adverse
treatment of: effect with Sucralfate (Carafate) is:

a. Hypertension a. Diarrhea
b. Diabetes b. Vomiting
c. Gout c. Constipation
d. Parkinson d. Bleeding

975. Tizanidine (Zanaflex) is a centrally acting: 981. Clomiphene (Clomid) is indicated for the
treatment of:
a. beta-1 receptor agonist
b. beta-2 receptor agonist a. Ovulatory dysfunction
c. alpha-1 receptor agonist b. Hypertension
d. alpha-2 receptor agonist c. Atherosclerosis
d. Rheumatoid arthritis
976. Fexofenadine (Allegra) is a(n):
982. Desmopressin (DDAVP) is a synthetic
a. Histamine H-1 receptor antagonist analogue of:
b. Alpha-1 receptor agonist
c. Dopamine D-1 receptor agonist a. thyroid hormone
d. Histamine H-2 receptor antagonist b. pituitary hormone
c. gonadotropic hormone
977. Dolasetron (Anzemet) is indicated for the d. parathyroid hormone
treatment of:

a. Hypertension
b. BPH

105